Is there a benefit to the lowest possible CA-125: The relationship between biomarkers and survival in epithelial ovarian cancer

被引：1
|
作者：
Clark, M. [1 ]
Al Houssan, L. [2 ]
Liu, Z. [3 ]
Bernardini, M. Q. [3 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Royal Coll Surgeons Ireland, Dublin, Ireland
[3] Univ Hlth Network, Princess Margaret Hosp, Toronto, ON, Canada
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2457
引用
收藏
页码：261 / 261
页数：1
相关论文
共 50 条
  • [21] SERUM CA-125 IN EPITHELIAL OVARIAN-CANCER - A LONGITUDINAL-STUDY
    BRIOSCHI, PA
    IRION, O
    BISCHOF, P
    BADER, M
    FORNI, M
    KRAUER, F
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (03): : 196 - 201
  • [22] Effect of topotecan on serum CA-125 in patients with advanced epithelial ovarian cancer
    Nielsen, HA
    Nielsen, D
    Engelholm, SA
    GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 383 - 388
  • [23] CA-125, A NEW MARKER FOR EPITHELIAL OVARIAN-CANCER - OUR EXPERIENCE
    PALOMBA, V
    MANENTE, G
    GIORDANO, G
    GAUDIO, R
    CIASCA, G
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1986, 5 (04) : 431 - 438
  • [24] CA-125 levels as a predictor for optimal cytoreductive surgery in epithelial ovarian cancer
    Modesto Trevino-Salinas, Emilio
    Ayuzo-del Valle, Cipatli
    de Jesus del Angel-Cervantes, Julio
    GACETA MEXICANA DE ONCOLOGIA, 2014, 13 (04): : 203 - 206
  • [25] OVARIAN-CANCER, INFLAMMATION, AND CA-125
    MARKMAN, M
    HOSKINS, WB
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (12) : 1049 - 1049
  • [26] USE OF CA-125 IN THE MANAGEMENT OF OVARIAN CANCER
    Mahner, S.
    Sehouli, J.
    Woelber, L.
    Jaenicke, F.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4033 - 4034
  • [27] The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer
    Rocconi, Rodney P.
    Matthews, Kellie S.
    Kemper, Meredith K.
    Hoskins, Kelly E.
    Huh, Warner K.
    Straughn, J. Michael, Jr.
    GYNECOLOGIC ONCOLOGY, 2009, 114 (02) : 242 - 245
  • [28] A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancer
    Chiang, An Jen
    Chen, Jiabin
    Chung, Yu-He
    Huang, Huan-Jung
    Liou, Wen Shiung
    Chang, Chung
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2014, 25 (01) : 51 - 57
  • [29] CA-125 IN OVARIAN-CANCER - RELATION BETWEEN HALF-LIFE, DOUBLING TIME AND SURVIVAL
    WILLEMSE, PHB
    AALDERS, JG
    DEBRUYN, HWA
    MULDER, NH
    SLEIJFER, DT
    DEVRIES, EGE
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (08) : 993 - 995
  • [30] USE OF CA-125 TO MONITOR PATIENTS WITH OVARIAN EPITHELIAL CARCINOMAS
    PODCZASKI, E
    WHITNEY, C
    MANETTA, A
    LARSON, JE
    KIRK, J
    STEVENS, CW
    LYTER, J
    MORTEL, R
    GYNECOLOGIC ONCOLOGY, 1989, 33 (02) : 193 - 197
12345